Stay updated on Trastuzumab Deruxtecan Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of trastuzumab deruxtecan in treating HER2-positive gastric cancer, while adding references to collaborators and a new revision number.SummaryDifference18%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check78 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check92 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.SummaryDifference0.9%
Stay in the know with updates to Trastuzumab Deruxtecan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan Clinical Trial page.